Cargando…

Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors

SIMPLE SUMMARY: Phosphoproteomics is essential for basic understanding of cell biology. However, analysis of the phosphoproteome remains far from comprehensive. Therefore, we proposed a new method to enrich a subset of the phosphoproteome and expand the scope of analysis by using in vitro kinase rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Kosuke, Takagi, Shunsuke, Sugiyama, Naoyuki, Ishihama, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817674/
https://www.ncbi.nlm.nih.gov/pubmed/36612075
http://dx.doi.org/10.3390/cancers15010078
_version_ 1784864802680602624
author Ogata, Kosuke
Takagi, Shunsuke
Sugiyama, Naoyuki
Ishihama, Yasushi
author_facet Ogata, Kosuke
Takagi, Shunsuke
Sugiyama, Naoyuki
Ishihama, Yasushi
author_sort Ogata, Kosuke
collection PubMed
description SIMPLE SUMMARY: Phosphoproteomics is essential for basic understanding of cell biology. However, analysis of the phosphoproteome remains far from comprehensive. Therefore, we proposed a new method to enrich a subset of the phosphoproteome and expand the scope of analysis by using in vitro kinase reactions. We showed our novel workflow identified and quantified the phosphopeptides which have not been observed in the conventional workflow. We also demonstrated that this method is effective for profiling kinase inhibitors. We envision our workflow could easily be adapted to target different subsets of the phosphoproteome by utilizing different sets of kinases, and should be applicable to variety of samples. ABSTRACT: We present a motif-targeting phosphoproteome analysis workflow utilizing in vitro kinase reaction to enrich a subset of peptides with specific primary sequence motifs. Phosphopeptides are enriched and dephosphorylated with alkaline phosphatase, followed by in vitro kinase reaction to phosphorylate substrate peptides with specific primary-sequence motifs. These phosphopeptides are enriched again, TMT-labeled, dephosphorylated to enhance MS-detectability, and analyzed by LC/MS/MS. We applied this approach to inhibitor-treated cancer cells, and successfully profiled the inhibitory spectra of multiple kinase inhibitors. We anticipate this approach will be applicable to target specific subsets of the phosphoproteome using the wide variety of available recombinant protein kinases.
format Online
Article
Text
id pubmed-9817674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98176742023-01-07 Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors Ogata, Kosuke Takagi, Shunsuke Sugiyama, Naoyuki Ishihama, Yasushi Cancers (Basel) Article SIMPLE SUMMARY: Phosphoproteomics is essential for basic understanding of cell biology. However, analysis of the phosphoproteome remains far from comprehensive. Therefore, we proposed a new method to enrich a subset of the phosphoproteome and expand the scope of analysis by using in vitro kinase reactions. We showed our novel workflow identified and quantified the phosphopeptides which have not been observed in the conventional workflow. We also demonstrated that this method is effective for profiling kinase inhibitors. We envision our workflow could easily be adapted to target different subsets of the phosphoproteome by utilizing different sets of kinases, and should be applicable to variety of samples. ABSTRACT: We present a motif-targeting phosphoproteome analysis workflow utilizing in vitro kinase reaction to enrich a subset of peptides with specific primary sequence motifs. Phosphopeptides are enriched and dephosphorylated with alkaline phosphatase, followed by in vitro kinase reaction to phosphorylate substrate peptides with specific primary-sequence motifs. These phosphopeptides are enriched again, TMT-labeled, dephosphorylated to enhance MS-detectability, and analyzed by LC/MS/MS. We applied this approach to inhibitor-treated cancer cells, and successfully profiled the inhibitory spectra of multiple kinase inhibitors. We anticipate this approach will be applicable to target specific subsets of the phosphoproteome using the wide variety of available recombinant protein kinases. MDPI 2022-12-23 /pmc/articles/PMC9817674/ /pubmed/36612075 http://dx.doi.org/10.3390/cancers15010078 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ogata, Kosuke
Takagi, Shunsuke
Sugiyama, Naoyuki
Ishihama, Yasushi
Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors
title Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors
title_full Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors
title_fullStr Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors
title_full_unstemmed Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors
title_short Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors
title_sort motif-targeting phosphoproteome analysis of cancer cells for profiling kinase inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817674/
https://www.ncbi.nlm.nih.gov/pubmed/36612075
http://dx.doi.org/10.3390/cancers15010078
work_keys_str_mv AT ogatakosuke motiftargetingphosphoproteomeanalysisofcancercellsforprofilingkinaseinhibitors
AT takagishunsuke motiftargetingphosphoproteomeanalysisofcancercellsforprofilingkinaseinhibitors
AT sugiyamanaoyuki motiftargetingphosphoproteomeanalysisofcancercellsforprofilingkinaseinhibitors
AT ishihamayasushi motiftargetingphosphoproteomeanalysisofcancercellsforprofilingkinaseinhibitors